Nuclear Medicine | The Medical City

About Us

The Medical City’s Department of Nuclear Medicine provides both diagnostic and therapeutic procedures for various organ systems through the use of radioactive substances. This branch of medicine highly involves the administration of radioactive substances to diagnose and treat diseases. The services are provided by Nuclear Medicine physicians and technologists trained in the safe use of radiopharmaceuticals for imaging and for treatment of a wide-spectrum of disease entities. Generally, Nuclear Medicine procedures are safe, non-invasive, and do not cause any discomfort to the patients.



Services

Nuclear Cardiology


A. Myocardial Perfusion Stress Testing


Treadmill

Dipyridamole

Dobutamine

Adenosine

B. MUGA (Cardiac Gated Blood Pool Study)

C. Infarct Avid Scintigraphy

D. SPECT TI201 – Tc99m Sestamibi Dual Isotope Studies


Radionuclide Therapy


A. Iodine131 Therapy for Toxic Goiter


Diffuse

Nodular

B. Iodine131 Therapy for Thyroid Cancer

C. Iodine131 MIBG

D. P32 for Polycythemia Vera

E. Selective Internal Radiation Therapy using Yttrium90


Intrahepatic Arterial MAA Breakthrough Scan

Yttrium90 Post Implantation Bremsstrahlung Scan

F. Radionuclide Bone Palliation using Samarium153

G. Radionuclide Bone Palliation using Strontium89


Dual Energy X-Ray Absorptiometry


A. Bone Densitometry


Central

Appendicular

Whole Body

B. Body Composition

C. Pediatrics

D. Vertebral Fracture Assessment


Radioimmunoassay


Free T3

Free T4

TSH

Thyroglobulin

TSH Receptor Antibody

Anti-Thyroglobulin Antibody and Thyroid Peroxidase (Antithyroid Microsomal Antibody)

Intact PTH (Parathyroid Hormone)

ACTH (Adrenocorticotropic Hormone)

Human Growth Hormone

Free Testosterone

Plasma Renin

Aldosterone

DHT (α-dihydrotestosterone)

Insulin-like growth factor 1

General Nuclear Medicine Scintigraphy


A. CNS (Central Nervous System)


HMPAO Brain Scan

Brain Perfusion using DTPA

B. Endocrine


Thyroid Scintigraphy using Tc99m and Iodine131

Thyroid Uptake using Tc99m and Iodine-131

Parathyroid Scintigraphy Dual Phase

Parathyroid Scintigraphy Dual Isotope (Tl201 and Tc99m)

Parathyroid Scintigraphy using Tc99m and Tc99m Sestamibi

Liver Scintigraphy with SPECT using Tc99m Sulfur Colloid

Liver Scintigraphy with SPECT using PYP for Hemangioma

Heat Damaged Spleen Scintigraphy

C. Respiratory


Lung Perfusion

Lung Ventilation using Tc99m DTPA Aerosol

D. Gastrointestinal


Gastric Emptying

Gastro Esophageal Reflux

Hepatobiliary Scintigraphy (HIDA)

Meckel’s Diverticulum Scintigraphy

G.I. Bleed Study (RBC Tagging) using PYP

Urea Breath Test

E. Genito-Urinary


Renal Scintigraphy using Tc99m DTPA

Renal Scintigraphy using Tc99m MAG3

Glomerular Filtration Rate using Gates Method

Plasma Clearance using Tc99m DTPA (In-Vitro GFR)

Renal Scintigraphy Diuretic Challenge

Renal Scintigraphy Captopril Challenge

Direct Cystography

Indirect Cystography

Testicular Blood Flow Scintigraphy

F. Miscellaneous


Salivary Gland Scintigraphy

Dacryoscintigraphy

Pleuroperitoneal Shunt Study

Ventriculo-peritoneal Study

Tc99m MAA Lung and Brain Scintigraphy in Hepatopulmonary Syndrome

Indium111 Octreotide

Tc99m-DTPA Octreotide

Radionuclide Cisternogram

Iodine131 MIBG Whole Body Scintigraphy

1Gallium67 Whole Body Scan with SPECT

Iodine131 Whole Body Scintigraphy

Indium111 WBC Scintigraphy

Lymphoscintigraphy

Sentinel Lymph Node Mapping (Melanoma and Breast Cancer)

Intra-operative Gamma Probe-guided Sentinel Node Biopsy

Scintimmamography

Thallium201 Whole Body Scintigraphy

G. Skeletal System


Whole Body Scan with SPECT

Triple-phase Bone Scan

 


SPECT-CT


TMC has acquired the first and only SPECT-CT or Single Photon Emission Computed Tomography-Computed Tomography in the country.


The Symbia T16 TruePoint SPECT-CT is a revolutionary diagnostic modality that provides a more precise, more reliable, and earlier diagnosis, thus significantly improving the patient’s chance of being cured. It offers increased speed over the other Symbia systems.


This high technology equipment can complete a full rotation in 0.5 seconds, yielding particular benefits for oncology screening when a large area must be covered in a short time. The system’s rapid scan time also makes it ideal for calcium scoring, providing detailed images of the coronary arteries in less than 20 seconds, irrespective of the heart beat.


UPDATES


Additional procedures


Tc99m-DTPA Octreotide

The test is for the diagnosis and staging of persons with primary and metastatic neuroendocrine tumors bearing somatostatin receptors.  Such tumors include any of the following:


Carcinoid tumors/carcinoid syndrome

Gastrinomas

Glucagonomas

Insulinomas

Islet cell tumors of the pancreas

Medullary thyroid carcinoma (MTC)

Neuroendocrine carcinoma of the rectum

Paragangliomas

Pheochromocytomas

Pituitary adenomas

Tumor-induced osteomalacia (oncogenic osteomalacia) (for diagnosis only)

VIPoma (vasoactive intestinal peptide) - persons present with Verner-Morrison syndrome: watery diarrhea, hypokalemia and achlorhydria

Radionuclide Cisternogram

This test determines if there is abnormal cerebrospinal fluid (CSF) flow within the brain and spinal canal termed hydrocephalus. It may also evaluate a suspected leak (also known as a CSF fistula) from the CSF cavity into the nasal cavity


Our Team

Dr. Angel M. De Guzman - Chief Consultant


Visiting Consultants

Dr. Edward-Bengie L. Magsombol (Nuclear Cardiologist)

Dr. Christopher A.G. Carbonell

Dr. Eddie A. Lim

Dr. Michele D. Ogbac

Dr. Eduardo Erasto S. Ongkeko

Dr. Enrique Leonardo P. Ote

Contact Us

Nuclear Medicine

The Medical City’s Department of Nuclear Medicine is located on the Lower Ground, Podium Bldg.
Operating Hours:
8:00 AM -7:00 PM Monday to Friday
8:00 AM – 12:00 NN Saturday
OFF Sunday

Phone:

8-988-1000 / 8-988-7000 locals 6130 / 6131

Email:

nucmed@themedicalcity.com

Contact Us

Phone:

Email: